CERS6

Across TCGA pan-cancer cohorts, CERS6 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CERS6’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where CERS6 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CERS6 is over-expressed in tumor.

LSCC, COAD, and LUAD are the cancer types where CERS6 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CERS6 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	All	+1.023	<.001	9	view →
COAD	Male	III,IV	+0.838	<.001	9	view →
LUAD	Female	All	+0.467	<.001	6	view →
OV	All	All	+0.559	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CERS6–LSCC

Open the LSCC breakdown →